The Department of Health and Human Services will create a Foundry for American Biotechnology to produce technological solutions to address health security threats and enhance daily medical care, the agency announced today. The foundry will be located in Manchester, N.H., and managed in conjunction with the Advanced Regenerative Manufacturing Institute led by DEKA Research Corp., as part of a public-private partnership with HHS’ Office of the Assistant Secretary for Preparedness and Response. Its first project, a partnership with the Defense Advanced Research Projects Agency, will focus on maturing and validating small, automated devices that could go to disaster locations to make necessary medicines on site.

Headline
The AHA will host a webinar Nov. 3 at 1 p.m. ET to discuss the cybersecurity, compliance and operational risks that can emerge when end-of-life technology is…
Headline
The Department of Justice Oct. 13 announced a series of actions disrupting a scheme by the North Korean government that involved placing remote IT workers in U…
Headline
A joint advisory issued Oct. 20 by U.S. and international agencies warns of recent activity by the SafePay Ransomware group. The group has been active since…
Headline
Two critical vulnerabilities have been discovered in Hypertext Preprocessor, or PHP, a widely-used open-source scripted language for web development, its…
Headline
John Riggi, AHA national advisor for cybersecurity and risk, and Brett Leatherman, assistant director of the FBI Cyber Division, break down Operation Riptide,…
Headline
The National Security Agency has issued guidance on reducing the risk of simple network management protocol abuse. SNMP consists of a standardized framework…